XP Labs Ephedrine
Natural health product licensed in Canada
- Licence holder
- 1852884 Ontario Inc. O/A Nutrition Club
- NPN or DIN-HM
- 80059727
- Status
- Active licence
- Licence date
- 9 April 2015
- Revision date
- 9 February 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| l-éphédrine Source : l-Éphédrine | 8 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Stéarate de magnésium, Croscarmellose de sodium, Cellulose microcristalline, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used as a decongestant to relieve nasal congestion due to common cold, flu, sinusitis, hay fever, allergic rhinitis or allergies.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking; or have taken in the past two weeks monoamine oxidase (MAO) inhibitors.
- Effets indésirables connus
Discontinue use if you experience insomnia, Irritability, dizziness, tremor, nausea, loss of appetite, rapid heartbeat, restlessness, severe headache, shortness of breath, or disturbance of urination.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for allergy symptoms, asthma, cough, cold, or weight control. Consult a healthcare practitioner prior to use if you are taking other products which contain caffeine, ephedrine, phenylpropanolamine or pseudoephedrine. Consult a health care practitioner prior to use if you have cardiovascular disease, diabetes, glaucoma, pre-existing psychiatric conditions, seizure disorders, thyroid problems, or difficulty in urination due to prostate enlargement. Keep out of reach of children.
Source
Official Health Canada record, licence 80059727
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging